Status:

Red

Decision Date:

November 2018

Comments

RED ^1,2: NICE TA682 - Preventing migraines in adults. (Decision date - April 2021) 

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again